Pfizer - Targeting the Immunopathogenesis of Ankylosing Spondylitis: Emerging Treatment Options


Industry room 5
English
Satellite Symposia
03 June 2021 08:15 - 09:45

Learning objective(s): 
  • To provide an overview on the immunopathogenesis of axial spondyloarthritis (axSpA) and how it is targeted to ameliorate disease manifestations
  • To discuss patients’ and physicians’ current treatment goals and unmet needs related to timely and correct diagnosis, and disease management 
  • To explore the role of existing and emerging advanced treatment options in addressing treatment priorities and unmet needs in axSpA including ankylosing spondylitis (AS)

Presentations

Title Time Calendar .ics
Welcome and Introduction
03 June 2021 08:15 - 08:20 .ics
Targeting the Immunopathogenesis of axSpA
03 June 2021 08:20 - 08:35 .ics
Treatment Goals in axSpA and Unmet Needs of Patients and Physicians
03 June 2021 08:35 - 08:55 .ics
The Role of Advanced Therapies in Addressing Unmet Needs in AS
03 June 2021 08:55 - 09:15 .ics
Faculty Discussion
03 June 2021 09:15 - 09:40 .ics
Summary and Close
03 June 2021 09:40 - 09:45 .ics